Compound Repurposing Using Chemical and Biological Data – On Types of Information and Lessons Learned
Andreas Bender · 2022
While drug repurposing has historically often been driven from clinical observations, the increasing amount of chemical and biological data available has led to a large increase of data-driven drug repurposing studies. In this presentation, we will review some of the studies from our own research in the area, and aim to derive some more general learnings on the information contents of chemical and biological data with respect to drug repurposing, with an emphasis on transcriptomics data.